Our current study investigated the role of ESR1 fusion genes in driving therapeutic resistance and metastasis in ER+ breast cancer.6 We identified a variety of in-frame and out-of-frame translocations involving ESR1 from RNA-seq analysis of primary and metastatic ER+ breast samples. Here, ESR1 is linked to breast carcinoma.